We are live on ! Find out more
LRND icon

New York Life Investments ETF Trust NYLIM U.S. Large Cap R&D Leaders ETF
LRND

1 hedge funds and large institutions have $3.79M invested in New York Life Investments ETF Trust NYLIM U.S. Large Cap R&D Leaders ETF in 2022 Q4 according to their latest regulatory filings, with funds opening new positions, increasing their positions, reducing their positions, and closing their positions.

New
Increased
Maintained
Reduced
Closed

4% more capital invested

Capital invested by funds: $3.65M → $3.79M (+$139K)

0% more funds holding

Funds holding: 1 → 1 (0)

0% more ownership

Funds ownership: 95% → 95% (0%)

Holders
1
Holders Change
–
Holders Change %
0%
% of All Funds
0.02%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
–
Increased
–
Reduced
–
Closed
–
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

No buyers this quarter

Top Sellers

No sellers this quarter

LRND Hedge Fund Activity: Q4 2022 in Review

1 of the 6,239 institutional investors tracked by Wall St. Rank reported a position in New York Life Investments ETF Trust NYLIM U.S. Large Cap R&D Leaders ETF (LRND) for Q4 2022, worth a combined $3.79M — up 3.8% from $3.65M a quarter earlier.

Fund positioning in LRND was balanced in Q4 2022: 0 funds opened new positions, 0 closed out, 0 added to existing stakes and 0 trimmed.

  • 1 institutional investor held New York Life Investments ETF Trust NYLIM U.S. Large Cap R&D Leaders ETF (LRND) as of Q4 2022, unchanged from Q3 2022.
  • Funds reported $3.79M of New York Life Investments ETF Trust NYLIM U.S. Large Cap R&D Leaders ETF stock for Q4 2022, up 3.8% quarter-over-quarter.
  • 0 funds opened new New York Life Investments ETF Trust NYLIM U.S. Large Cap R&D Leaders ETF positions in Q4 2022 and 0 closed out.

Based on aggregated 13F filings for Q4 2022.